Charles N. York II, MBA ’06, has been appointed as Chief Operating and Financial Officer for Day One Biopharmaceuticals, a clinical-stage biopharmaceutical company focused on accelerating new, promising targeted therapies for children and adults with cancer. He brings more than 20 years of strategic capital formation and leadership experience to Day One.

Congratulations to Charles! Read more here.